Skip to main content
  • Advertise
    Want to Advertise with Us?
    Conquer welcomes advertising and sponsorship collaborations with reputable companies offering high-quality products and services to people affected by cancer.
  • Affiliated Brands
    Academy of Oncology Nurse & Patient Navigators
    The Academy of Oncology Nurse & Patient Navigators (AONN+) is the largest national specialty organization dedicated to improving patient care and quality of life by defining, enhancing, and promoting the role of oncology nurse and patient navigators. Our organization of over 8,900 members was founded in May 2009 to provide a network for all professionals involved and interested in patient navigation and survivorship care services to better manage the complexities of the cancer care treatment continuum for their patients. We view our organization as one consisting of “professional patient advocates” and, to that end, we support and serve our members.
    Journal of Oncology Navigation & Survivorship
    The Journal of Oncology Navigation & Survivorship (JONS) promotes reliance on evidence-based practices in navigating patients with cancer and their caregivers through diagnosis, treatment, and survivorship. JONS also seeks to strengthen the role of nurse and patient navigators in cancer care by serving as a platform for these professionals to disseminate original research findings, exchange best practices, and find support for their growing community.
    The Oncology Nurse-APN/PA
    The Oncology Nurse-APN/PA (TON) provides coverage of the wide spectrum of oncology-related events, trends, news, therapeutics, diagnostics, organizations, and legislation that directly affect hematology/oncology nurses and advanced practitioners involved in healthcare delivery and product utilization. The scope and coverage include a unique presentation of news and events that are shaping the care of patients with cancer.
  • Healthcare Providers
  • Contribute

October 2022 Vol 8 No 5

Addressing Disparities in the Care of Patients with Triple-Negative Breast Cancer
Triple-negative breast cancer is an aggressive cancer that is often diagnosed at later stages. Dr. Gary discusses the many alarming gaps in the quality of care for Black and Hispanic women. Read More ›

Traditional versus Alternative Therapies: What Is the Difference?
Dr. Forrestal breaks down the differences between traditional medicine, which relies on scientific evidence to prove its benefits, and alternative therapies, which can promise cures without any evidence. Read More ›

Listening to Yourself: Lessons from My Triple-Negative Breast Cancer Diagnosis
Ann Glover found a lump on her chest in 2020, and learned the negative emotional impact a doctor can have on a patient by delivering news in an uncaring manner. Read More ›

Painting Helped Me Get Through Cancer Treatment
Painting gave Pamela Davis much needed peace and tranquility while receiving chemotherapy, after being diagnosed with stage IV non-Hodgkin lymphoma in 2019. Read More ›

A Breast Cancer Diagnosis and Stumbling into Advocacy in Nigeria
Ngozi Ejedimu was diagnosed with breast cancer at age 39, after having a benign lump removed at age 19, and after experiencing firsthand the uninformed Nigerian breast cancer culture, she became an advocate for health literacy for Nigerian women. Read More ›

Enhertu First Drug Approved for Patients with HER2-Low Breast Cancer

My Race to Be Cancer-Free
Sara Gilles, an athlete and physical therapist who completed several Ironman triathlons, was shocked by her breast cancer diagnosis in her early 50s. Her husband had to tell others about her diagnosis, because she was too traumatized to say “I have breast cancer.” Read More ›

When Cancer Asked Me What I Was Made Of
After a 20-year career as a biomedical breast cancer researcher, Dr. Dana Brantley-Sieders was diagnosed with breast cancer and discovered that her scientific expertise didn’t prepare her for the challenges she faced as a patient. Read More ›

Lytgobi Newest Drug Approved for Patients with FGFR2-Positive Cholangiocarcinoma

Imfinzi Approved for Advanced or Metastatic Biliary Tract Cancer

Page 2 of 3